Literature DB >> 9634507

Sequence homology between 4qter and 10qter loci facilitates the instability of subtelomeric KpnI repeat units implicated in facioscapulohumeral muscular dystrophy.

S Cacurri1, N Piazzo, G Deidda, E Vigneti, G Galluzzi, L Colantoni, B Merico, E Ricci, L Felicetti.   

Abstract

Physical mapping and in situ hybridization experiments have shown that a duplicated locus with a structural organization similar to that of the 4q35 locus implicated in facioscapulohumeral muscular dystrophy is present in the subtelomeric portion of 10q. We performed sequence analysis of the p13E-11 probe and of the adjacent KpnI tandem-repeat unit derived from a 10qter cosmid clone and compared our results with those published, by other laboratories, for the 4q35 region. We found that the sequence homology range is 98%-100% and confirmed that the only difference that can be exploited for differentiation of the 10qter from the 4q35 alleles is the presence of an additional BlnI site within the 10qter KpnI repeat unit. In addition, we observed that the high degree of sequence homology does facilitate interchromosomal exchanges resulting in displacement of the whole set of BlnI-resistant or BlnI-sensitive KpnI repeats from one chromosome to the other. However, partial translocations escape detection if the latter simply relies on the hybridization pattern from double digestion with EcoRI/BlnI and with p13E-11 as a probe. We discovered that the restriction enzyme Tru9I cuts at both ends of the array of KpnI repeats of different chromosomal origins and allows the use of cloned KpnI sequences as a probe by eliminating other spurious fragments. This approach coupled with BlnI digestion permitted us to investigate the structural organization of BlnI-resistant and BlnI-sensitive units within translocated chromosomes of 4q35 and 10q26 origin. A priori, the possibility that partial translocations could play a role in the molecular mechanism of the disease cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9634507      PMCID: PMC1377230          DOI: 10.1086/301906

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  18 in total

1.  Evidence for subtelomeric exchange of 3.3 kb tandemly repeated units between chromosomes 4q35 and 10q26: implications for genetic counselling and etiology of FSHD1.

Authors:  J C van Deutekom; E Bakker; R J Lemmers; M J van der Wielen; E Bik; M H Hofker; G W Padberg; R R Frants
Journal:  Hum Mol Genet       Date:  1996-12       Impact factor: 6.150

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  The evolutionary distribution and structural organization of the homeobox-containing repeat D4Z4 indicates a functional role for the ancestral copy in the FSHD region.

Authors:  S T Winokur; U Bengtsson; J C Vargas; J J Wasmuth; M R Altherr; B Weiffenbach; S J Jacobsen
Journal:  Hum Mol Genet       Date:  1996-10       Impact factor: 6.150

4.  Characterization of a tandemly repeated 3.3-kb KpnI unit in the facioscapulohumeral muscular dystrophy (FSHD) gene region on chromosome 4q35.

Authors:  J H Lee; K Goto; C Matsuda; K Arahata
Journal:  Muscle Nerve Suppl       Date:  1995

5.  The FSHD-linked locus D4F104S1 (p13E-11) on 4q35 has a homologue on 10qter.

Authors:  E Bakker; C Wijmenga; R H Vossen; G W Padberg; J Hewitt; M van der Wielen; K Rasmussen; R R Frants
Journal:  Muscle Nerve Suppl       Date:  1995

Review 6.  Position-effect variegation and the new biology of heterochromatin.

Authors:  G H Karpen
Journal:  Curr Opin Genet Dev       Date:  1994-04       Impact factor: 5.578

7.  Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy.

Authors:  J E Hewitt; R Lyle; L N Clark; E M Valleley; T J Wright; C Wijmenga; J C van Deutekom; F Francis; P T Sharpe; M Hofker
Journal:  Hum Mol Genet       Date:  1994-08       Impact factor: 6.150

8.  4q35 molecular probes for the diagnosis and genetic counseling of facioscapulohumeral muscular dystrophy.

Authors:  G C Deidda; S Cacurri; I La Cesa; C Scoppetta; L Felicetti
Journal:  Ann Neurol       Date:  1994-07       Impact factor: 10.422

9.  Direct detection of 4q35 rearrangements implicated in facioscapulohumeral muscular dystrophy (FSHD).

Authors:  G Deidda; S Cacurri; N Piazzo; L Felicetti
Journal:  J Med Genet       Date:  1996-05       Impact factor: 6.318

10.  Physical mapping evidence for a duplicated region on chromosome 10qter showing high homology with the facioscapulohumeral muscular dystrophy locus on chromosome 4qter.

Authors:  G Deidda; S Cacurri; P Grisanti; E Vigneti; N Piazzo; L Felicetti
Journal:  Eur J Hum Genet       Date:  1995       Impact factor: 4.246

View more
  14 in total

1.  De novo facioscapulohumeral muscular dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10.

Authors:  S M van der Maarel; G Deidda; R J Lemmers; P G van Overveld; M van der Wielen; J E Hewitt; L Sandkuijl; B Bakker; G J van Ommen; G W Padberg; R R Frants
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  A new dosage test for subtelomeric 4;10 translocations improves conventional diagnosis of facioscapulohumeral muscular dystrophy (FSHD).

Authors:  S M van der Maarel; G Deidda; R J Lemmers; E Bakker; M J van der Wielen; L Sandkuijl; J E Hewitt; G W Padberg; R R Frants
Journal:  J Med Genet       Date:  1999-11       Impact factor: 6.318

3.  Cephalometric findings in facioscapulohumeral muscular dystrophy patients with obstructive sleep apneas.

Authors:  Giacomo Della Marca; Francesca Pantanali; Roberto Frusciante; Emanuele Scarano; Alessandro Cianfoni; Lea Calò; Serena Dittoni; Catello Vollono; Anna Losurdo; Elisa Testani; Salvatore Colicchio; Valentina Gnoni; Elisabetta Iannaccone; Benedetto Farina; Tommaso Pirronti; Pietro A Tonali; Enzo Ricci
Journal:  Sleep Breath       Date:  2010-02-20       Impact factor: 2.816

4.  Decreased nocturnal movements in patients with facioscapulohumeral muscular dystrophy.

Authors:  Giacomo Della Marca; Roberto Frusciante; Serena Dittoni; Catello Vollono; Anna Losurdo; Elisa Testani; Emanuele Scarano; Salvatore Colicchio; Elisabetta Iannaccone; Pietro A Tonali; Enzo Ricci
Journal:  J Clin Sleep Med       Date:  2010-06-15       Impact factor: 4.062

5.  Lack of cytosolic and transmembrane domains of type XIII collagen results in progressive myopathy.

Authors:  A P Kvist; A Latvanlehto; M Sund; L Eklund; T Väisänen; P Hägg; R Sormunen; J Komulainen; R Fässler; T Pihlajaniemi
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

Review 6.  The cell biology of disease: FSHD: copy number variations on the theme of muscular dystrophy.

Authors:  Daphne Selvaggia Cabianca; Davide Gabellini
Journal:  J Cell Biol       Date:  2010-12-13       Impact factor: 10.539

Review 7.  The role of genetics in the establishment and maintenance of the epigenome.

Authors:  Covadonga Huidobro; Agustin F Fernandez; Mario F Fraga
Journal:  Cell Mol Life Sci       Date:  2013-03-10       Impact factor: 9.261

8.  Genetic and epigenetic characteristics of FSHD-associated 4q and 10q D4Z4 that are distinct from non-4q/10q D4Z4 homologs.

Authors:  Weihua Zeng; Yen-Yun Chen; Daniel A Newkirk; Beibei Wu; Judit Balog; Xiangduo Kong; Alexander R Ball; Simona Zanotti; Rabi Tawil; Naohiro Hashimoto; Ali Mortazavi; Silvère M van der Maarel; Kyoko Yokomori
Journal:  Hum Mutat       Date:  2014-06-24       Impact factor: 4.878

9.  A long ncRNA links copy number variation to a polycomb/trithorax epigenetic switch in FSHD muscular dystrophy.

Authors:  Daphne S Cabianca; Valentina Casa; Beatrice Bodega; Alexandros Xynos; Enrico Ginelli; Yujiro Tanaka; Davide Gabellini
Journal:  Cell       Date:  2012-04-26       Impact factor: 41.582

10.  Hypermethylation of genomic 3.3-kb repeats is frequent event in HPV-positive cervical cancer.

Authors:  Alexey N Katargin; Larissa S Pavlova; Fjodor L Kisseljov; Natalia P Kisseljova
Journal:  BMC Med Genomics       Date:  2009-05-27       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.